» Articles » PMID: 39273571

Protein Kinase C-Delta Mediates Cell Cycle Reentry and Apoptosis Induced by Amyloid-Beta Peptide in Post-Mitotic Cortical Neurons

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2024 Sep 14
PMID 39273571
Authors
Affiliations
Soon will be listed here.
Abstract

Amyloid-beta peptide (Aβ) is a neurotoxic constituent of senile plaques in the brains of Alzheimer's disease (AD) patients. The detailed mechanisms by which protein kinase C-delta (PKCδ) contributes to Aβ toxicity is not yet entirely understood. Using fully differentiated primary rat cortical neurons, we found that inhibition of Aβ25-35-induced PKCδ increased cell viability with restoration of neuronal morphology. Using cyclin D1, proliferating cell nuclear antigen (PCNA), and histone H3 phosphorylated at Ser-10 (p-Histone H3) as the respective markers for the G1-, S-, and G2/M-phases, PKCδ inhibition mitigated cell cycle reentry (CCR) and subsequent caspase-3 cleavage induced by both Aβ25-35 and Aβ1-42 in the post-mitotic cortical neurons. Upstream of PKCδ, signal transducers and activators of transcription (STAT)-3 mediated PKCδ induction, CCR, and caspase-3 cleavage upon Aβ exposure. Downstream of PKCδ, aberrant neuronal CCR was triggered by overactivating cyclin-dependent kinase-5 (CDK5) via calpain2-dependent p35 cleavage into p25. Finally, PKCδ and CDK5 also contributed to Aβ25-35 induction of p53-upregulated modulator of apoptosis (PUMA) in cortical neurons. Together, we demonstrated that, in the post-mitotic neurons exposed to Aβs, STAT3-dependent PKCδ expression triggers calpain2-mediated p35 cleavage into p25 to overactivate CDK5, thus leading to aberrant CCR, PUMA induction, caspase-3 cleavage, and ultimately apoptosis.

Citing Articles

Potential Roles of Hypoxia-Inducible Factor-1 in Alzheimer's Disease: Beneficial or Detrimental?.

Lin T, Huang C, Lin K, Hsieh Y, Chen S, Lin Y Antioxidants (Basel). 2024; 13(11).

PMID: 39594520 PMC: 11591038. DOI: 10.3390/antiox13111378.

References
1.
Bhounsule A, Bhatt L, Prabhavalkar K, Oza M . Cyclin dependent kinase 5: A novel avenue for Alzheimer's disease. Brain Res Bull. 2017; 132:28-38. DOI: 10.1016/j.brainresbull.2017.05.006. View

2.
Zhao C, Li K, Li J, Zheng W, Liang X, Geng A . PKCdelta regulates cortical radial migration by stabilizing the Cdk5 activator p35. Proc Natl Acad Sci U S A. 2009; 106(50):21353-8. PMC: 2781735. DOI: 10.1073/pnas.0812872106. View

3.
Sahin B, Hawasli A, Greene R, Molkentin J, Bibb J . Negative regulation of cyclin-dependent kinase 5 targets by protein kinase C. Eur J Pharmacol. 2008; 581(3):270-5. PMC: 2268033. DOI: 10.1016/j.ejphar.2007.11.061. View

4.
Gschwendt M, Muller H, Kielbassa K, Zang R, Kittstein W, Rincke G . Rottlerin, a novel protein kinase inhibitor. Biochem Biophys Res Commun. 1994; 199(1):93-8. DOI: 10.1006/bbrc.1994.1199. View

5.
Malik B, Currais A, Andres A, Towlson C, Pitsi D, Nunes A . Loss of neuronal cell cycle control as a mechanism of neurodegeneration in the presenilin-1 Alzheimer's disease brain. Cell Cycle. 2008; 7(5):637-46. DOI: 10.4161/cc.7.5.5427. View